These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM. Chan RK; Verna N; Afnan J; Zhang M; Ibrahim S; Carroll MC; Moore FD Surgery; 2006 Feb; 139(2):236-43. PubMed ID: 16455333 [TBL] [Abstract][Full Text] [Related]
4. Reperfusion injury to skeletal muscle affects primarily type II muscle fibers. Chan RK; Austen WG; Ibrahim S; Ding GY; Verna N; Hechtman HB; Moore FD J Surg Res; 2004 Nov; 122(1):54-60. PubMed ID: 15522315 [TBL] [Abstract][Full Text] [Related]
5. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation. Holers VM; Kulik L Mol Immunol; 2007 Jan; 44(1-3):64-72. PubMed ID: 16876864 [TBL] [Abstract][Full Text] [Related]
6. Ischemia-mediated aggregation of the actin cytoskeleton is one of the major initial events resulting in ischemia-reperfusion injury. Shi T; Moulton VR; Lapchak PH; Deng GM; Dalle Lucca JJ; Tsokos GC Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G339-47. PubMed ID: 19095765 [TBL] [Abstract][Full Text] [Related]
7. The role of natural IgM in myocardial ischemia-reperfusion injury. Zhang M; Michael LH; Grosjean SA; Kelly RA; Carroll MC; Entman ML J Mol Cell Cardiol; 2006 Jul; 41(1):62-7. PubMed ID: 16781728 [TBL] [Abstract][Full Text] [Related]
8. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. Fleming SD; Shea-Donohue T; Guthridge JM; Kulik L; Waldschmidt TJ; Gipson MG; Tsokos GC; Holers VM J Immunol; 2002 Aug; 169(4):2126-33. PubMed ID: 12165541 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein and natural IgM antibodies are activators of complement in a rat model of intestinal ischemia and reperfusion. Padilla ND; van Vliet AK; Schoots IG; Valls Seron M; Maas MA; Peltenburg EE; de Vries A; Niessen HW; Hack CE; van Gulik TM Surgery; 2007 Nov; 142(5):722-33. PubMed ID: 17981193 [TBL] [Abstract][Full Text] [Related]
11. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Zhang M; Austen WG; Chiu I; Alicot EM; Hung R; Ma M; Verna N; Xu M; Hechtman HB; Moore FD; Carroll MC Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3886-91. PubMed ID: 14999103 [TBL] [Abstract][Full Text] [Related]
12. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy. Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880 [TBL] [Abstract][Full Text] [Related]
13. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury. He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222 [TBL] [Abstract][Full Text] [Related]
15. CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent. Woods KM; Pope MR; Hoffman SM; Fleming SD J Immunol; 2011 Feb; 186(3):1755-62. PubMed ID: 21187447 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement. Imai M; Ohta R; Varela JC; Song H; Tomlinson S Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064 [TBL] [Abstract][Full Text] [Related]
17. Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury. Atkinson C; Qiao F; Yang X; Zhu P; Reaves N; Kulik L; Goddard M; Holers VM; Tomlinson S Circulation; 2015 Mar; 131(13):1171-80. PubMed ID: 25825397 [TBL] [Abstract][Full Text] [Related]